Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Deli Tan"'
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-22 (2023)
Abstract Background STIL centriolar assembly protein (STIL) is a cytoplasmic protein implicated in cellular growth and proliferation as well as chromosomal stability, which abnormal condition affected tumor immunity and tumor progression. However, th
Externí odkaz:
https://doaj.org/article/96a4913c69184516bb343f65a9ec0d88
Autor:
Weijie Ma, Ye Yao, Gang Xu, Xiaoling Wu, Jinghua Li, Ganggang Wang, Xi Chen, Kunlei Wang, Yirang Chen, Yonghua Guo, Yongsheng Li, Deli Tan, Hui Guo, Zhisu Liu, Yufeng Yuan, Francois X. Claret
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Hepatocellular carcinoma (HCC) is a leading cause of cancer death worldwide, accounting for over 700,000 deaths each year. The lack of predictive and prognostic biomarkers for HCC, with effective therapy, remains a significant challenge for
Externí odkaz:
https://doaj.org/article/ee37639dc35b475b946f2ed67983c9cb
Autor:
Shirong Zhang, Longwen Xu, Jinteng Feng, Deli Tan, Yue Zhu, Jia Hou, Wenyuan Li, Kejia Lv, Wenjuan Wang, Lili Jiang, Min Jiao, Hui Guo
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Anti-silencing function 1B (ASF1B), a histone H3-H4 chaperone, is crucial for S-phase progression and cell proliferation. Recent studies have shown that ASF1B may be used as a new proliferation marker for cancer prognosis. However, the pr
Externí odkaz:
https://doaj.org/article/de4a8ab2e9bf4b07a7a9b28f27e16720
Autor:
Shixin Zhang, Deli Tan, Wei Wu, Bo He, Tao Jing, Meng Tang, Tao Wu, Hongxiang Liu, Ming Zhang, Ni Zhou, Lingfeng Tang, Qiao Chen, Jinghua Tang, Mei Xia, Aihong Huang, Yi Liao, Yang Qiu, Haidong Wang
Publikováno v:
Thoracic Cancer, Vol 10, Iss 9, Pp 1846-1851 (2019)
Background How to maximally improve the drainage of intracranial and upper body venous and to reduce neurological complications during thoracic tumor‐causedsuperior vena cava replacement are still clinical problems to be solved. Methods We have inn
Externí odkaz:
https://doaj.org/article/edc1770659164f4b9d30f601007ede6d
Autor:
SiZhe Yu, Yu Wang, Jia Hou, WenYuan Li, Xiao Wang, LuoChengLing Xiang, DeLi Tan, WenJuan Wang, LiLi Jiang, Francois X Claret, Min Jiao, Hui Guo
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0231003 (2020)
Systematic interrogation of tumor-infiltrating immune cells (TIICs) is key to the prediction of clinical outcome and development of immunotherapies. However, little is known about the TIICs of hepatocellular carcinoma (HCC) and its impact on the prog
Externí odkaz:
https://doaj.org/article/65490ee47b1c44429dc0bb9eb8a3d023
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1921-1932 (2018)
Abstract Multidrug resistance (MDR) often leads to chemotherapy failure of lung cancer and has been linking to the cellular expression of several DNA transcription‐ and repair‐related genes such as Trps1 and MGMT. However, their roles in the form
Externí odkaz:
https://doaj.org/article/f9ca1c64a2bf4ab8af433c76d651a9da
Publikováno v:
Bioengineered, Vol 13, Iss 1, Pp 1838-1857 (2022)
Bioengineered
article-version (VoR) Version of Record
Bioengineered
article-version (VoR) Version of Record
Non-small-cell lung cancer (NSCLC) is defined as the most universally diagnosed class of lung cancer. Cisplatin (DDP) is an effective drug for NSCLC, but tumors are prone to drug resistance. The current study set out to evaluate the regulatory effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a335f575d6f04d9ead2bc1799e55565
https://doaj.org/article/a84131a5ef0d4f67a5c6e6f97cdde09b
https://doaj.org/article/a84131a5ef0d4f67a5c6e6f97cdde09b
The incidence of small cell lung cancer (SCLC) in females has markedly increased over the last decades. However, sex differences in SCLC lack large database-based studies. The present study was aimed at exploring sex differences in SCLC. We used 1823
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2637648a54c4f4f1de25ea0082355b33
https://doi.org/10.21203/rs.3.rs-1653002/v1
https://doi.org/10.21203/rs.3.rs-1653002/v1
Publikováno v:
Annals of Clinical & Laboratory Science; Jan/Feb2023, Vol. 53 Issue 1, p64-75, 12p
Autor:
Tao Jing, Yi Liao, Bo He, Jinghua Tang, Mei Xia, Wei Wu, Hongxiang Liu, Deli Tan, Tao Wu, Lingfeng Tang, Haidong Wang, Meng Tang, Qiao Chen, Ni Zhou, Yang Qiu, Shixin Zhang, Aihong Huang, Ming Zhang
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 10, Iss 9, Pp 1846-1851 (2019)
Thoracic Cancer, Vol 10, Iss 9, Pp 1846-1851 (2019)
Background How to maximally improve the drainage of intracranial and upper body venous and to reduce neurological complications during thoracic tumor‐causedsuperior vena cava replacement are still clinical problems to be solved. Methods We have inn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c2af914649c5ccef73c281e32310d3
https://doi.org/10.1111/1759-7714.13140
https://doi.org/10.1111/1759-7714.13140